Elevance Health Proceeds from issuance of common stock relating to employee stock plans remained flat by 0.0% to $19.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 64.3%, from $55.25M to $19.75M. Over 3 years (FY 2022 to FY 2025), Proceeds from issuance of common stock relating to employee stock plans shows a downward trend with a -24.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher proceeds generally correlate with higher employee participation in equity plans and can indicate positive sentiment regarding the company's long-term stock performance.
Cash inflows resulting from the exercise of employee stock options or purchases through employee stock purchase plans. T...
Standard for most publicly traded companies with equity-based compensation programs.
financing_proceeds_from_stock_plans| FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|
| Value | $182.00M | $152.00M | $221.00M | $79.00M |
| YoY Change | — | -16.5% | +45.4% | -64.3% |